Capital Investment Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $467K | Buy |
7,124
+1,588
| +29% | +$104K | 0.01% | 467 |
|
|
2025
Q1 | $391K | Buy |
5,536
+150
| +3% | +$10.6K | 0.01% | 483 |
|
|
2024
Q4 | $354K | Buy |
5,386
+1,751
| +48% | +$115K | 0.01% | 483 |
|
|
2024
Q3 | $257K | Sell |
3,635
-172
| -5% | -$12.1K | 0.01% | 559 |
|
|
2024
Q2 | $252K | Buy |
3,807
+2
| +0.1% | +$133 | 0.01% | 527 |
|
|
2024
Q1 | $258K | Buy |
3,805
+1
| +0% | +$68 | 0.01% | 525 |
|
|
2023
Q4 | $235K | Buy |
+3,804
| New | +$235K | 0.01% | 534 |
|